© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Microbot Medical Inc. (MBOT) stock declined over -0.53%, trading at $1.86 on NASDAQ, down from the previous close of $1.87. The stock opened at $1.87, fluctuating between $1.83 and $1.88 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 09, 2026 | 1.88 | 1.88 | 1.83 | 1.86 | 476.05K |
| Jul 08, 2026 | 1.86 | 1.90 | 1.83 | 1.87 | 654.99K |
| Jul 07, 2026 | 1.97 | 2.02 | 1.87 | 1.90 | 1.13M |
| Jul 06, 2026 | 1.92 | 1.97 | 1.91 | 1.93 | 431.8K |
| Jul 02, 2026 | 1.92 | 1.98 | 1.87 | 1.91 | 766.03K |
| Jul 01, 2026 | 1.94 | 2.04 | 1.91 | 1.91 | 1.57M |
| Jun 30, 2026 | 1.90 | 1.98 | 1.88 | 1.95 | 1.16M |
| Jun 29, 2026 | 1.80 | 1.88 | 1.77 | 1.87 | 913.32K |
| Jun 26, 2026 | 1.76 | 1.81 | 1.76 | 1.77 | 663.92K |
| Jun 25, 2026 | 1.81 | 1.82 | 1.76 | 1.77 | 614.39K |
| Jun 24, 2026 | 1.82 | 1.83 | 1.77 | 1.79 | 508.47K |
| Jun 23, 2026 | 1.79 | 1.90 | 1.78 | 1.82 | 891.8K |
| Jun 22, 2026 | 1.85 | 1.90 | 1.83 | 1.85 | 1.1M |
| Jun 18, 2026 | 1.88 | 1.91 | 1.81 | 1.86 | 1.05M |
| Jun 17, 2026 | 1.84 | 1.91 | 1.83 | 1.88 | 738.78K |
| Jun 16, 2026 | 1.87 | 1.89 | 1.82 | 1.82 | 860.1K |
| Jun 15, 2026 | 1.84 | 1.86 | 1.81 | 1.82 | 801.91K |
| Jun 12, 2026 | 1.78 | 1.82 | 1.76 | 1.78 | 919.86K |
| Jun 11, 2026 | 1.78 | 1.83 | 1.76 | 1.82 | 599.18K |
| Jun 10, 2026 | 1.80 | 1.84 | 1.77 | 1.77 | 577.92K |
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
| Employees | 20 |
| Beta | 1.03 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |